tirzepatide and fatty liver Eli Lilly touts tirzepatide's midstage MASH win Let’s talk about Tirzepatide and

SdLDL particles, readily oxidised and/or glycated, have potent atherogenic activity

This pause was intentional and designed to support and sustain balloon efficacy after the initial phase, allowing the Semaglutide to be reintroduced after balloon removal in the seventh and eighth months to consolidate weight loss and support behavioral change

those focused on longevity and cellular optimization Metabolic Health Anti-Aging Primary BenefitMitochondrial optimization, improved insulin sensitivity, enhanced fat metabolism, and cellular energy regulation Timeline46 weeks (energy, metabolism)

the timing is just less predictable